News
Clinical CRO ICRC-Weyer To Enhance Pharmacovigilance Risk Management
www.firmenpresse.de
Jan 08, · At the event, Dr Ulrike Treichel, Head of Pharmacovigilance at ICRC-Weyer, presented her findings and experiences in striking a balanced medical review process to build a robust Pharmacovigilance strategy.
ICRC-Weyer To Boost Drug Safety Services For Investigator Trials
www.firmenpresse.de
‘A large amount of IITs are oncology trials which generally bear a lot of adverse events (AEs) and serious adverse events (SAEs)’ says Dr Ulrike Treichel, Head of Pharmacovigilance at ICRC-Weyer. ‘Many of these events are unrelated to the drug in question. The SAE review process can be a substantial administrative burden for trial sponsors.
ICRC-Weyer To Expand Pharmacovigilance Firmenpresse
www.firmenpresse.de
... Safety Update Reports, Periodic Safety Update Reports, Risk Management Plans and more' says Dr Ulrike Treichel, Head of Pharmacovigilance at ICRC-Weyer. › pressrelease › icr...
sortiert nach Relevanz / Datum